Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$530K Buy
2,397
+760
+46% +$186K 0.01% 353
2025
Q4
$415K Sell
1,637
-51
-3% -$12.8K 0.01% 392
2025
Q3
$418K Sell
1,688
-325
-16% -$77.8K 0.01% 395
2025
Q2
$484K Sell
2,013
-17
-0.8% -$3.96K 0.01% 379
2025
Q1
$460K Sell
2,030
-34
-2% -$7.48K 0.01% 368
2024
Q4
$424K Buy
2,064
+12
+0.6% +$2.63K 0.01% 375
2024
Q3
$498K Hold
2,052
0.01% 362
2024
Q2
$450K Hold
2,052
0.01% 363
2024
Q1
$461K Buy
2,052
+59
+3% +$13.3K 0.01% 357
2023
Q4
$438K Sell
1,993
-512
-20% -$108K 0.01% 358
2023
Q3
$550K Sell
2,505
-130
-5% -$29.4K 0.02% 304
2023
Q2
$593K Buy
2,635
+131
+5% +$26.2K 0.02% 299
2023
Q1
$479K Buy
2,504
+317
+14% +$61.3K 0.01% 324
2022
Q4
$404K Buy
2,187
+96
+5% +$16.9K 0.01% 326
2022
Q3
$347K Buy
2,091
+140
+7% +$28.5K 0.01% 330
2022
Q2
$402K Buy
1,951
+23
+1% +$5.19K 0.01% 316
2022
Q1
$466K Buy
1,928
+89
+5% +$20.6K 0.02% 309
2021
Q4
$447K Buy
1,839
+260
+16% +$59.4K 0.01% 312
2021
Q3
$323K Buy
1,579
+582
+58% +$125K 0.01% 335
2021
Q2
$206K Buy
+997
New +$201K 0.01% 399

Other funds holding STE

Glenview Trust's STE Position: Q1 2026 in Review

Glenview Trust increased its Steris (STE) stake by 46% in Q1 2026, buying an estimated $186K and bringing the position to 2,397 shares worth $530K. The position accounts for 0.01% of the portfolio, ranked #353.

Glenview Trust first reported a position in STE in Q2 2021 and has held it in 20 quarters since. The position peaked at $593K in Q2 2023. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Glenview Trust held 2,397 shares of Steris worth $530K as of Q1 2026.
  • Glenview Trust bought 760 Steris shares in Q1 2026, an estimated $186K.
  • Steris made up 0.01% of Glenview Trust's portfolio in Q1 2026, its #353 holding.
  • Glenview Trust first reported a position in Steris in Q2 2021 and has held it in 20 quarters since.
  • Glenview Trust's Steris position peaked at $593K in Q2 2023.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.